China Digest: Meilian snags $14m; Sinovation invests in DPI

Beijing Meilian Tyco Biotechnology has secured 100 million yuan ($14 million) in a Series B round of financing led by Zero2IPO Asset Management while DPI has bagged 80 million yuan ($11 million) in a Series A round from China Merchants Venture, Sinovation Ventures, and Yunqi Capital.